Osteoporosis
Conditions
Keywords
osteoporosis
Brief summary
Clinical trials for osteoporosis are designed to assess the safety and effectiveness of novel osteoporosis treatments. These trials play a crucial role in establishing whether these new treatments outperform existing options and provide substantial evidence to support their adoption within the wider population. The primary aim of this particular study is to investigate the experiences of individuals diagnosed with osteoporosis who participate in a distinct clinical trial involving a medical intervention. The focus will be on closely monitoring the rates of trial completion and withdrawal among these participants.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Patient has been diagnosed with osteoporosis * Patient has self-identified as planning to enroll in an observational clinical trial * Patient is a minimum of 18 years or older
Exclusion criteria
* Pregnant or nursing patients * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients who decide to join in an osteoporosis clinical trial | 3 months |
| Rate of patients who remain in osteoporosis clinical trial to trial completion | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed